Bank of America’s BiondVax Pharmaceuticals Ltd. BVXVW Stock Holding History

Bank of America’s Portfolio BVXVW Stock Details BVXVW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,000	Closed	-$5K	–	7498
2019 Q4	$5K	Buy	+2,000	New	+$2.65K	﹤0.01%	6785

Other funds holding BVXVW

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Bank of America's BVXVW Position: Q1 2020 in Review

Bank of America sold out of BiondVax Pharmaceuticals Ltd. (BVXVW) in Q1 2020, closing a stake of 2,000 shares — an estimated $5K sold.

Bank of America first reported a position in BVXVW in Q4 2019 and held it in 1 quarter. The position peaked at $5K in Q4 2019. 2 funds tracked by Wall St. Rank hold BVXVW as of Q1 2020.

Bank of America reported no remaining BiondVax Pharmaceuticals Ltd. position as of Q1 2020 after selling out during the quarter.
Bank of America sold 2,000 BiondVax Pharmaceuticals Ltd. shares in Q1 2020, an estimated $5K.
Bank of America first reported a position in BiondVax Pharmaceuticals Ltd. in Q4 2019 and held it in 1 quarter.
Bank of America's BiondVax Pharmaceuticals Ltd. position peaked at $5K in Q4 2019.
2 funds tracked by Wall St. Rank held BiondVax Pharmaceuticals Ltd. as of Q1 2020.

Based on Bank of America's 13F filing for Q1 2020, filed 15 May 2020.